Amarin Corp Plcuk (AMRN) Change in Inventory (2012 - 2026)
Amarin Corp Plcuk (AMRN) reported Change in Inventory of -$12.3 million for Q1 2026, up 11.29% year-over-year from -$11.1 million in Q1 2025, and down 686.63% quarter-over-quarter from $2.1 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Change in Inventory (2012 - 2026) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 15 years of Change in Inventory data on file, last reported at -$12.3 million in Q1 2026.
- Change in Inventory for Q1 2026 came in at -$12.3 million, up 11.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$33.3 million (up 70.42% YoY), and the FY2025 annual result was -$34.9 million, up 66.92% from the prior year.
- Change in Inventory fell to -$12.3 million in Q1 2026 per AMRN's latest filing, from $2.1 million in the prior quarter.
- Over five years, Change in Inventory peaked at $52.9 million in Q1 2022 and troughed at -$67.2 million in Q4 2024.
- A 5-year average of -$10.1 million and a median of -$12.7 million in 2024 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2024 and 2025: Change in Inventory plunged 570.87% in 2024, then surged 103.12% in 2025.
- A 5-year view of Change in Inventory shows it stood at -$23.2 million in 2022, then jumped by 56.84% to -$10.0 million in 2023, then sank by 570.87% to -$67.2 million in 2024, then jumped by 103.12% to $2.1 million in 2025, then tumbled by 686.63% to -$12.3 million in 2026.
- Business Quant data shows AMRN's Change in Inventory at -$12.3 million in Q1 2026, $2.1 million in Q4 2025, and -$17.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 431.00 Mn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 184.00 Mn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | - |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | -18.00 Mn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 52.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | -14.00 Mn |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn | -12.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.33 Mn |
| Mar 31, 2026 | -12.33 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Sep 30, 2025 | -17.02 Mn |
| Sep 30, 2025 | -17.02 Mn |
| Jun 30, 2025 | -6.06 Mn |
| Jun 30, 2025 | -6.06 Mn |
| Mar 31, 2025 | -13.89 Mn |
| Mar 31, 2025 | -13.89 Mn |
| Dec 31, 2024 | -67.24 Mn |
| Dec 31, 2024 | -67.24 Mn |
| Sep 30, 2024 | -12.68 Mn |
| Sep 30, 2024 | -12.68 Mn |
| Jun 30, 2024 | -18.80 Mn |
| Jun 30, 2024 | -18.80 Mn |
| Mar 31, 2024 | -6.73 Mn |
| Mar 31, 2024 | -6.73 Mn |
| Dec 31, 2023 | -10.02 Mn |
| Dec 31, 2023 | -10.02 Mn |